Samantha DiGrande

Treating Clostridioides difficile infection is complicated in patients coinfected with COVID-19. However, a new study suggests a significant benefit of fecal microbiota transplant (FMT) in these coinfected patients.

In a new study, Michigan State University investigators identified an immune receptor, SLAMF7, that had the ability to decrease immune response when activated on monocytes.